Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Van Lint

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Immunotherapy|May 11, 2011
mRNA: delivering an antitumor message?Sandra Van Lint, Kris Thielemans, Karine Breckpot
Human Vaccines & Immunotherapeutics|January 8, 2013
mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeuticSandra Van Lint, Carlo Heirman, Kris Thielemans, et al.
Frontiers in Immunology|March 8, 2021
Dendritic Cell-Based Immunotherapy in Lung CancerDieter Stevens, Joline Ingels, Sandra Van Lint, et al.
Oncoimmunology|July 9, 2015
Intratumoral delivery of mRNA: Overcoming obstacles for effective immunotherapyKevin Van der Jeught, Sandra Van Lint, Kris Thielemans, et al.
Journal of Biotechnology|July 20, 2010
Large double copy vectors are functional but show a size-dependent decline in transduction efficiencyTomas J Bos, Elke De Bruyne, Sandra Van Lint, et al.
International Journal of Cancer|August 29, 2013
Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterpartsSarah K Maenhout, Sandra Van Lint, Perpetua U Emeagi, et al.
Molecular Cancer|March 4, 2021
mRNA in cancer immunotherapy: beyond a source of antigenLien Van Hoecke, Rein Verbeke, Heleen Dewitte, et al.
Journal of Virology|March 19, 2010
HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7Karine Breckpot, David Escors, Frederick Arce, et al.
Expert Review of Vaccines|September 30, 2014
The ReNAissanCe of mRNA-based cancer therapySandra Van Lint, Dries Renmans, Katrijn Broos, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2014
The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapyHeleen Dewitte, Sandra Van Lint, Carlo Heirman, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Immunotherapy|May 11, 2011
mRNA: delivering an antitumor message?Sandra Van Lint, Kris Thielemans, Karine Breckpot
Human Vaccines & Immunotherapeutics|January 8, 2013
mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeuticSandra Van Lint, Carlo Heirman, Kris Thielemans, et al.
Frontiers in Immunology|March 8, 2021
Dendritic Cell-Based Immunotherapy in Lung CancerDieter Stevens, Joline Ingels, Sandra Van Lint, et al.
Oncoimmunology|July 9, 2015
Intratumoral delivery of mRNA: Overcoming obstacles for effective immunotherapyKevin Van der Jeught, Sandra Van Lint, Kris Thielemans, et al.
Journal of Biotechnology|July 20, 2010
Large double copy vectors are functional but show a size-dependent decline in transduction efficiencyTomas J Bos, Elke De Bruyne, Sandra Van Lint, et al.
International Journal of Cancer|August 29, 2013
Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterpartsSarah K Maenhout, Sandra Van Lint, Perpetua U Emeagi, et al.
Molecular Cancer|March 4, 2021
mRNA in cancer immunotherapy: beyond a source of antigenLien Van Hoecke, Rein Verbeke, Heleen Dewitte, et al.
Journal of Virology|March 19, 2010
HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7Karine Breckpot, David Escors, Frederick Arce, et al.
Expert Review of Vaccines|September 30, 2014
The ReNAissanCe of mRNA-based cancer therapySandra Van Lint, Dries Renmans, Katrijn Broos, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2014
The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapyHeleen Dewitte, Sandra Van Lint, Carlo Heirman, et al.
Pageof 4